Literature DB >> 33585012

Proteomic study of advanced cirrhosis based on HCV to reveal potential biomarkers.

Akram Safaei1, Afsaneh Arefi Oskouie2, Seyed Reza Mohebbi3, Zahra Razaghi4, Naser Nejadi1.   

Abstract

AIM: We aimed to carry out proteomic assessment of long-term effects of hepatitis C on liver.
BACKGROUND: Cirrhosis is a condition where liver is damaged and loses its efficiency, and has the high rate of mortality in the world. Proteome profiling may help to identify important proteins and find the pathogenesis Cirrhosis is a condition where liver is damaged and loses its efficiency, and has the high rate of mortality in the world. Proteome profiling may help to identify important proteins and find the pathogenesis.
METHODS: Here, by the application of two-dimensional polyacrylamide gel electrophoresis (2-D PAGE), combined with (MALDI-TOF-TOF MS), proteome profile of decompensated HCV cirrhosis is determined compared to healthy matched controls. Furthermore, Cytoscape has used network analysis. The proteome comparison between two groups identified proteins with significant expression changes (p<0.05 and fold change ≥ 1.5).
RESULTS: We found upregulation of IGHA1, C3, A1BG, IGKC and one isoform of HP. Also, lower expression of APOA4 and the other spot of HP in advanced cirrhosis patients were revealed based on HCV compared to matched controls. According to network analysis, ALB has been introduced as a key protein, which may play an important role in pathogenesis.
CONCLUSION: Integration of the proteomics with protein interaction data led to the identification of several novel key proteins related to the immune system that may reflect the long-term effects of hepatitis C virus on the liver, and can introduce as therapeutic targets for advanced HCV- cirrhosis. ©2020 RIGLD, Research Institute for Gastroenterology and Liver Diseases.

Entities:  

Keywords:  Protein –protein interaction; Proteomic; Two-dimensional gel electrophoresis (2DE); hepatitis C; liver cirrhosis

Year:  2020        PMID: 33585012      PMCID: PMC7881408     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol Bed Bench        ISSN: 2008-2258


  44 in total

Review 1.  Treatment of hepatitis C in patients with cirrhosis: remaining challenges for direct-acting antiviral therapy.

Authors:  Avik Majumdar; Matthew T Kitson; Stuart K Roberts
Journal:  Drugs       Date:  2015-05       Impact factor: 9.546

2.  Lipid parameters predicting liver function in patients with cirrhosis and after liver transplantation.

Authors:  U J Tietge; K H Boker; M J Bahr; S Weinberg; R Pichlmayr; H H Schmidt; M P Manns
Journal:  Hepatogastroenterology       Date:  1998 Nov-Dec

Review 3.  Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver.

Authors:  Scott L Friedman
Journal:  Physiol Rev       Date:  2008-01       Impact factor: 37.312

4.  Assessing liver fibrosis with serum marker models.

Authors:  Enrico Rossi; Leon A Adams; Max Bulsara; Gary P Jeffrey
Journal:  Clin Biochem Rev       Date:  2007-02

5.  The effect of the severity of liver cirrhosis on the level of lipids and lipoproteins.

Authors:  Lech Chrostek; Lukasz Supronowicz; Anatol Panasiuk; Bogdan Cylwik; Ewa Gruszewska; Robert Flisiak
Journal:  Clin Exp Med       Date:  2014-11       Impact factor: 3.984

6.  Ethanol and Cancer Induce Similar Changes on Protein Expression Pattern of Human Fibroblast Cell.

Authors:  Mona Zamanian-Azodi; Mostafa Rezaei-Tavirani; Sara Rahmati-Rad; Majid Rezaei Tavirani
Journal:  Iran J Pharm Res       Date:  2016       Impact factor: 1.696

7.  ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks.

Authors:  Gabriela Bindea; Bernhard Mlecnik; Hubert Hackl; Pornpimol Charoentong; Marie Tosolini; Amos Kirilovsky; Wolf-Herman Fridman; Franck Pagès; Zlatko Trajanoski; Jérôme Galon
Journal:  Bioinformatics       Date:  2009-02-23       Impact factor: 6.937

8.  Several Human Liver Cell Expressed Apolipoproteins Complement HCV Virus Production with Varying Efficacy Conferring Differential Specific Infectivity to Released Viruses.

Authors:  Kathrin Hueging; Romy Weller; Mandy Doepke; Gabrielle Vieyres; Daniel Todt; Benno Wölk; Florian W R Vondran; Robert Geffers; Chris Lauber; Lars Kaderali; François Penin; Thomas Pietschmann
Journal:  PLoS One       Date:  2015-07-30       Impact factor: 3.240

9.  Quantitative proteomic analysis in HCV-induced HCC reveals sets of proteins with potential significance for racial disparity.

Authors:  Simon T Dillon; Manoj K Bhasin; Xiaoxing Feng; David W Koh; Sayed S Daoud
Journal:  J Transl Med       Date:  2013-10-01       Impact factor: 5.531

10.  Protein-protein interaction network analysis of cirrhosis liver disease.

Authors:  Akram Safaei; Mostafa Rezaei Tavirani; Afsaneh Arefi Oskouei; Mona Zamanian Azodi; Seyed Reza Mohebbi; Abdol Rahim Nikzamir
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2016
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.